Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (263)
- Legislation (86)
- COVID-19 (66)
- Compliance and enforcement (56)
- Vaping hub (48)
- Manufacturing (31)
- Import and export (24)
- Labelling and packaging (21)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (15)
- Weight loss products (7)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
720 result(s) found, displaying 401 to 425
-
Media releasesThe Federal Court of Australia has ordered Evolution Supplements Australia and its Director to pay $12 million
-
Media releasesThe TGA has issued four infringement notices totalling $10,656 to a Sydney-based individual, for alleged unlawful advertising of Cannabidiol Oil in breach of the Therapeutic Goods Act 1989.
-
Media releasesPI used by healthcare professionals updated
-
Media releasesThe TGA has issued an infringement notice for $2,664 to an individual from Canberra, for a breach of the Therapeutic Goods Act 1989 in relation to the alleged unlawful advertising of a homoeopathic medicine with COVID-19 claims.
-
Regulatory decision noticesThis instrument is made under subregulations 4A.2(4) of the Therapeutic Goods (Medical Devices) Regulations 2002.
-
Media releasesJoint ICMRA/WHO Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness.
-
Media releasesThe TGA has issued seven infringement notices totalling $93,240 to Melbourne-based global biopharmaceutical company Starpharma Holdings Limited (Starpharma), for alleged illegal advertising of a nasal spray that is not approved for use in Australia.
-
Media releasesThe TGA granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen, making it the third COVID-19 vaccine to receive regulatory approval in Australia.
-
Media releasesThe TGA, part of the Department of Health, has granted provisional determination to Moderna Australia Pty Ltd in relation to the COVID-19 Vaccine, Elasomeran
-
Media releasesInteraction between TGA and AHPRA advertising guidelines
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to Sydney company Aidacare Pty Ltd (Aidacare).
-
Media releasesThe TGA is seriously concerned about misleading information that has been broadcast on radio stations providing a distorted picture of the safety of COVID-19 vaccines.
-
Media releasesThe TGA has implemented arrangements to facilitate the communication of information about approved COVID-19 vaccines.
-
Media releasesThe TGA has issued three infringement notices to a Queensland man for the alleged unlawful importation of a medicine containing Armodafinil.
-
Media releasesThe TGA has issued two infringement notices to a dentist from Western Australia for the alleged unlawful importation of cosmetic injectables.
-
Media releasesThe TGA has issued two infringement notices to Perth-based company V P & Associates Pty Ltd (V P & Associates), for alleged unlawful advertising of a medical device in relation to SARS-CoV-2 Human Coronavirus.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Media releasesThe TGA is warning sponsors not to advertise listed medicines that are not included in the ARTG with permitted indications
-
Media releasesPeter Evans Chef Pty Ltd fined $79,920 for alleged unlawful advertising
-
Media releasesThe infringement notice relate to the alleged failure to provide information on a contact person responsible for medicine safety.
-
Media releasesGlobal Therapeutics Pty Ltd has paid penalties of $119,880 in response to nine infringement notices
-
Media releasesUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
-
Media releasesTGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
-
Media releasesThe TGA is investigating the advertising of stem cell therapies to ensure that content in the public domain complies with the Australian rules for advertising therapeutic goods.
-
Media releasesSome rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.